Long-Term Efficacy and Safety of Guselkumab in Psoriasis Patients Who Failed Anti-IL17: A Two-Year Real-Life Study. - Megna, Matteo; Ruggiero, Angelo; Martora, Fabrizio; Vallone, Ylenia; Guerrasio, Gianluca; Potestio, Luca (Journal of Clinical Medicine, 2024)